# Mecillinam for Treatment of Genital Chlamydia Infection

> **NCT02083276** · PHASE2 · TERMINATED · sponsor: **Oslo University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Chlamydia Trachomatis Infection
- Chlamydial Urethritis

## Interventions

- **DRUG:** Pivmecillinamhydrochlorid

## Key facts

- **NCT ID:** NCT02083276
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Treatment failure on study medication observed
- **Last updated:** 2015-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083276, "Mecillinam for Treatment of Genital Chlamydia Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02083276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*